Advertisement

Reducing the Risk of Sudden Unexpected Death in Epilepsy (SUDEP)

  • Lance Watkins
  • Rohit Shankar
Epilepsy (E Waterhouse, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Epilepsy

Abstract

Purpose of Review

Recent reports have highlighted an increase in the number of epilepsy-related deaths. Sudden unexpected death in epilepsy (SUDEP) is thought to be the number one cause of death in chronic epilepsy. This review provides a summary of the current evidence of how to communicate, stratify, and mitigate known risk factors for SUDEP.

Recent Findings

There is now a clearer understanding of the possible pathological mechanisms that contribute to SUDEP. SUDEP is the culmination of multifactorial predisposing and precipitating factors and has been linked to particular candidate genes. A number of static and modifiable risk factors for SUDEP have been consistently identified. Recent guidance has emphasised the importance of communicating SUDEP risk to individuals at the earliest appropriate time.

Summary

SUDEP risk assessment should be integral to the care of individuals with epilepsy. The use of evidence-based risk assessment tools may provide an opportunity to communicate identified risks in a person-centred holistic way. There is increasing evidence to support the use of wearable seizure monitoring devices to help reduce the frequency and impact of convulsive seizures, perhaps the number one risk factor for SUDEP.

Keywords

Risk factors Preventable death Mechanism 

Notes

Compliance with Ethical Standards

Conflict of Interest

Rohit Shankar is a stakeholder of the ‘SUDEP and Seizure Safety Checklist’. Rohit Shankar is a principal developer and key stakeholder of EpSMon. Rohit Shankar has received institutional and research support and personal fees from LivaNova, UCB, Eisai, Special Products, Bial and Desitin.

Lance Watkins has no disclosures to report.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    De Boer HM, Mula M, Sander JW. The global burden and stigma of epilepsy. Epilepsy Behav. 2008;12(4):540–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Office for National Statistics Death registrations summary table, England and Wales. 2013Google Scholar
  3. 3.
    Deaths associated with neurological conditions in England 2001 to 2014 Data analysis report. Public Health England. 2018. This recent publication highlights an alarming trend of increased mortality rates associated with neurological conditions including epilepsy.Google Scholar
  4. 4.
    Sander JW, Bell GS. Reducing mortality: an important aim of epilepsy management. J Neurol Neurosurg Psychiatry. 2004;75:349–51.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Nashef L, So EL, Ryvlin P, Tomson T. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia. 2012;53(2):227–33.CrossRefPubMedGoogle Scholar
  6. 6.
    Hesdorffer DC, Tomson T, Benn E, Sander JW, Nilsson L, Langan Y, et al. Combined analysis of risk factors for SUDEP. Epilepsia. 2011;52(6):1150–9.CrossRefPubMedGoogle Scholar
  7. 7.
    •• Tomson T, Surges R, Delamont R, Haywood S, Hesdorffer DC. Who to target in sudden unexpected death in epilepsy prevention and how? Risk factors, biomarkers, and intervention study designs. Epilepsia. 2016;57(S1):4–16. This paper summarises the current evidence on identified SUDEP risk factors.CrossRefPubMedGoogle Scholar
  8. 8.
    Surges R, Sander JW. Sudden unexpected death in epilepsy: mechanisms, prevalence, and prevention. Curr Opin Neurol. 2012;25(2):201–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Shmuely S, Van der Lende M, Lamberts RJ, Sander JW, Thijs RD. The heart of epilepsy: current views and future concepts. Seizure. 2017;44:176–83.CrossRefPubMedGoogle Scholar
  10. 10.
    Devinsky O, Hesdorffer DC, Thurman DJ, Lhatoo S, Richerson G. Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention. Lancet Neurol. 2016;15(10):1075–88.CrossRefPubMedGoogle Scholar
  11. 11.
    Ryvlin P, Nashef L, Lhatoo SD, Bateman LM, Bird J, Bleasel A, et al. Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study. Lancet Neurol. 2013;12(10):966–77.CrossRefPubMedGoogle Scholar
  12. 12.
    Goldman AM, Behr ER, Semsarian C, Bagnall RD, Sisodiya S, Cooper PN. Sudden unexpected death in epilepsy genetics: molecular diagnostics and prevention. Epilepsia. 2016;57(S1):17–25.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Tu E, Bagnall RD, Duflou J, Semsarian C. Post-mortem review and genetic analysis of sudden unexpected death in epilepsy (SUDEP) cases. Brain Pathol. 2011;21(2):201–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Bagnall RD, Crompton DE, Petrovski S, Lam L, Cutmore C, Garry SI, et al. Exome-based analysis of cardiac arrhythmia, respiratory control, and epilepsy genes in sudden unexpected death in epilepsy. Ann Neurol. 2016;79(4):522–34.CrossRefPubMedGoogle Scholar
  15. 15.
    Hodges MR, Wehner M, Aungst J, Smith JC, Richerson GB. Transgenic mice lacking serotonin neurons have severe apnea and high mortality during development. J Neurosci. 2009;29(33):10341–10,349.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    •• Harden C, Tomson T, Gloss D, Buchhalter J, Cross JH, Donner E, et al. Practice guideline summary: sudden unexpected death in epilepsy incidence rates and risk factors Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2017;88(17):1674–80. Guidance on good practice and communication of risk.CrossRefPubMedGoogle Scholar
  17. 17.
    The National Institute for Health and Care Excellence (NICE). The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE clinical guideline 137. 2012. guidance.nice.org.uk/cg137
  18. 18.
    Mclean B, Shankar R, et al. SUDEP – measures to reduce risk. Pract Neurol. 2017;17:13–20.CrossRefPubMedGoogle Scholar
  19. 19.
    Shankar R, Donner EJ, McLean B, Nashef L, Tomson T. Sudden unexpected death in epilepsy (SUDEP): what every neurologist should know. Epileptic Disord. 2017;19(1):1–9.PubMedGoogle Scholar
  20. 20.
    Shankar R, Newman C, Gales A, McLean BN, Hanna J, Ashby S, et al. Has the time come to stratify and score SUDEP risk to inform people with epilepsy of their changes in safety? Front Neurol. 2018;9.  https://doi.org/10.3389/fneur.2018.00281.
  21. 21.
    •• Maguire MJ, Jackson CF, Marson AG, Nolan SJ. Treatments for the prevention of sudden unexpected death in epilepsy (SUDEP). Cochrane Database Syst Rev. 2016;7:CD011792. Cochrane review of current SUDEP prevention evidencePubMedGoogle Scholar
  22. 22.
    Shankar R, Cox D, Jalihal V, Brown S, Hanna J, McLean B. Sudden unexpected death in epilepsy (SUDEP): development of a safety checklist. Seizure. 2013;22(10):812–7.CrossRefPubMedGoogle Scholar
  23. 23.
    •• Shankar R, Walker M, McLean B, Laugharne R, Ferrand F, Hanna J, et al. Steps to prevent SUDEP: the validity of risk factors in the SUDEP and seizure safety checklist: a case control study. J Neurol. 2016;263(9):1840–6. Evidence to support the use of an evidence-based, structured risk assessment tool to communicate risk.CrossRefPubMedGoogle Scholar
  24. 24.
    Shankar R, Newman C, McLean B, Anderson T, Obe JH. Can technology help reduce risk of harm in patients with epilepsy? Br J Gen Pract. 2015;65(638):448–9.  https://doi.org/10.3399/bjgp15X686413.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Shankar R, Henley W, Boland C, Laugharne R, McLean BN, Newman C, et al. Decreasing the risk of SUDEP: structured communication of risk factors for premature mortality in people with epilepsy. Eur J Neurol. 2018;  https://doi.org/10.1111/ene.13651.CrossRefPubMedGoogle Scholar
  26. 26.
    Newman C, Shankar R, Hanna J, McLean B, Osland A, Milligan C, et al. Developing an evidence-based epilepsy risk assessment ehealth solution: from concept to market. JMIR Res Protoc. 2016;5(2):e82.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    DeGiorgio CM, Miller P, Meymandi S, Chin A, Epps J, Gordon S, et al. RMSSD, a measure of vagus-mediated heart rate variability, is associated with risk factors for SUDEP: the SUDEP-7 Inventory. Epilepsy Behav. 2010;19(1):78–81.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    DeGiorgio CM, Markovic D, Mazumder R, Moseley BD. Ranking the leading risk factors for sudden unexpected death in epilepsy. Front Neurol. 2017;8:473.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Langan Y, Nashef L, Sander JW. Case-control study of SUDEP. Neurology. 2005;64(7):1131–3.CrossRefPubMedGoogle Scholar
  30. 30.
    Ryvlin P, Cucherat M, Rheims S. Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials. Lancet Neurol. 2011;10(11):961–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Lamberts RJ, Thijs RD, Laffan A, Langan Y, Sander JW. Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk. Epilepsia. 2012;53(2):253–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Liebenthal JA, Wu S, Rose S, Ebersole JS, Tao JX. Association of prone position with sudden unexpected death in epilepsy. Neurology. 2015;84(7):703–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Shmuely S, Surges R, Sander JW, Thijs RD. Prone sleeping and SUDEP risk: the dynamics of body positions in nonfatal convulsive seizures. Epilepsy Behav. 2016;62:176–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Sperling MR, Feldman H, Kinman J, Liporace JD, O’Connor MJ. Seizure control and mortality in epilepsy. Ann Neurol. 1999;46(1):45–50.CrossRefPubMedGoogle Scholar
  35. 35.
    Annegers JF, Coan SP, Hauser WA, Leestma J. Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death. Epilepsia. 2000;41(5):549–53.CrossRefPubMedGoogle Scholar
  36. 36.
    Granbichler CA, Nashef L, Selway R, Polkey CE. Mortality and SUDEP in epilepsy patients treated with vagus nerve stimulation. Epilepsia. 2015;56(2):291–6.CrossRefPubMedGoogle Scholar
  37. 37.
    Ryvlin P, So EL, Gordon CM, Hesdorffer DC, Sperling MR, Devinsky O, et al. Long-term surveillance of SUDEP in drug-resistant epilepsy patients treated with VNS therapy. Epilepsia. 2018;59:562–72.  https://doi.org/10.1111/epi.14002.CrossRefPubMedGoogle Scholar
  38. 38.
    Devinsky O, Friedman D, Duckrow RB, Fountain NB, Gwinn RP, Leiphart JW, et al. Sudden unexpected death in epilepsy in patients treated with brain-responsive neurostimulation. Epilepsia. 2018;  https://doi.org/10.1111/epi.13998.CrossRefPubMedGoogle Scholar
  39. 39.
    •• Jory C, Shankar R, Coker D, McLean B, Hanna J, Newman C. Safe and sound? A systematic literature review of seizure detection methods for personal use. Seizure. 2016;36:4–15. Systematic review of technology-based seizure detection devices.CrossRefPubMedGoogle Scholar
  40. 40.
    Arends J, Van Hoek D, Van Mierlo P, Van Dorp J, Kramer N, Van Der Vorst D, et al. Diagnostic accuracy of audio based seizure detection in patients with severe epilepsy and a mental impairment. Epilepsy Behav. 2016;62:180–5.CrossRefPubMedGoogle Scholar
  41. 41.
    Narechania AP, Garić II, Sen-Gupta I, Macken MP, Gerard EE, Schuele SU. Assessment of a quasi-piezoelectric mattress monitor as a detection system for generalized convulsions. Epilepsy Behav. 2013;28(2):172–6.CrossRefPubMedGoogle Scholar
  42. 42.
    Poppel KV, Fulton SP, McGregor A, Ellis M, Patters A, Wheless J. Prospective study of the Emfit movement monitor. J Child Neurol. 2013;28(11):1434–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Fulton S, Poppel KV, McGregor A, Ellis M, Patters A, Wheless J. Prospective study of 2 bed alarms for detection of nocturnal seizures. J Child Neurol. 2013;28(11):1430–3.CrossRefPubMedGoogle Scholar
  44. 44.
    Carlson C, Arnedo V, Cahill M, Devinsky O. Detecting nocturnal convulsions: efficacy of the MP5 monitor. Seizure-European Journal of Epilepsy. 2009;18(3):225–7.CrossRefPubMedGoogle Scholar
  45. 45.
    Shankar R, Jory C, Tripp M, Cox D, Hagenow K. Monitoring nocturnal seizure in vulnerable patients. Learn Disabil Pract. 2013;16(9):36.CrossRefGoogle Scholar
  46. 46.
    Cuppens K, Chen CW, Wong KBY, Van de Vel A, Lagae L, Ceulemans B, Tuytelaars T, Van Huffel S, Vanrumste B, Aghajan H. Integrating video and accelerometer signals for nocturnal epileptic seizure detection. In Proceedings of the 14th ACM international conference on Multimodal interaction. 2012; (pp. 161–164). ACM.Google Scholar
  47. 47.
    Lockman J, Fisher RS, Olson DM. Detection of seizure-like movements using a wrist accelerometer. Epilepsy Behav. 2011;20(4):638–41.CrossRefPubMedGoogle Scholar
  48. 48.
    Beniczky S, Polster T, Kjaer TW, Hjalgrim H. Detection of generalized tonic–clonic seizures by a wireless wrist accelerometer: a prospective, multicenter study. Epilepsia. 2013:54(4).CrossRefPubMedGoogle Scholar
  49. 49.
    Cuppens K, Karsmakers P, Van de Vel A, Bonroy B, Milosevic M, Luca S, et al. Accelerometry-based home monitoring for detection of nocturnal hypermotor seizures based on novelty detection. IEEE J Biomed Health Informatics. 2014;18(3):1026–33.CrossRefGoogle Scholar
  50. 50.
    Onorati F, Regalia G, Caborni C, Migliorini M, Bender D, Poh MZ, et al. Multicenter clinical assessment of improved wearable multimodal convulsive seizure detectors. Epilepsia. 2017;58(11):1870–9.CrossRefPubMedGoogle Scholar
  51. 51.
    Massé F, Penders J, Serteyn A, van Bussel M, Arends J. Miniaturized wireless ECG-monitor for real-time detection of epileptic seizures. In Wireless Health. 2010; (pp. 111–117). ACM.Google Scholar
  52. 52.
    Vandecasteele K, De Cooman T, Gu Y, Cleeren E, Claes K, Paesschen WV, et al. Automated epileptic seizure detection based on wearable ECG and PPG in a hospital environment. Sensors. 2017;17(10):2338.CrossRefGoogle Scholar
  53. 53.
    Rodriguez-Villegas E, Chen G, Radcliffe J, Duncan J. A pilot study of a wearable apnea detection device. BMJ open. 2014;4(10):e005299.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Cavazos J, Girouard M, Whitmire L. Novel ambulatory EMG-based GTC seizure detection device for home & hospital use (I6-4B). Neurology. 2015;84(14 Supplement):I6–4B.Google Scholar
  55. 55.
    Graves J, Arjona J, Gourraud PA. Wearable electromyogram device associated with disability outcomes in adults with multiple sclerosis (P1.377). Neurology. 2017;88(16 Supplement)Google Scholar
  56. 56.
    Poh MZ, Loddenkemper T, Reinsberger C, Swenson NC, Goyal S, Sabtala MC, Madsen JR, Picard RW. Convulsive seizure detection using a wrist-worn electrodermal activity and accelerometry biosensor. Epilepsia, 2012; 53(5).CrossRefPubMedGoogle Scholar
  57. 57.
    Picard RW, Migliorini M, Caborni C, Onorati F, Regalia G, Friedman D, et al. Wrist sensor reveals sympathetic hyperactivity and hypoventilation before probable SUDEP. Neurology. 2017;89(6):633–5.CrossRefPubMedGoogle Scholar
  58. 58.
    Ge A, Gonzalez E, Lee SW, Carmenate Y, Collard M, Dixon-Salazar T, Crone N, Krauss G. Seizure triggers in epilepsy patients: a national perspective, American Academy of Neurology 69th Annual Meeting. 2017; (S37. 002).Google Scholar
  59. 59.
    Hampel KG, Jahanbekam A, Elger CE, Surges R. Seizure-related modulation of systemic arterial blood pressure in focal epilepsy. Epilepsia. 2016;57(10):1709–18.CrossRefPubMedGoogle Scholar
  60. 60.
    Hampel KG, Elger CE, Surges R. Impaired baroreflex sensitivity after bilateral convulsive seizures in patients with focal epilepsy. Front Neurol. 2017;8:210.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Dupuis M, Van Rijckevorsel K, Evrard F, Dubuisson N, Dupuis F, Van Robays P. Takotsubo syndrome (TKS): a possible mechanism of sudden unexplained death in epilepsy (SUDEP). Seizure. 2012;21(1):51–4.CrossRefPubMedGoogle Scholar
  62. 62.
    Monté CPJA, Arends JBAM, Tan IY, Aldenkamp AP, Limburg M, De Krom MCTFM. Sudden unexpected death in epilepsy patients: risk factors: a systematic review. Seizure. 2007;16(1):1–7.CrossRefPubMedGoogle Scholar
  63. 63.
    Sveinsson O, Andersson T, Carlsson S, Tomson T. The incidence of SUDEP: a nationwide population-based cohort study. Neurology. 2017:10–1212.Google Scholar
  64. 64.
    Faingold CL, Tupal S, Randall M. Prevention of seizure-induced sudden death in a chronic SUDEP model by semichronic administration of a selective serotonin reuptake inhibitor. Epilepsy Behav. 2011;22(2):186–90.CrossRefPubMedGoogle Scholar
  65. 65.
    Watkins L, Shankar R, Sander JW. Identifying and mitigating sudden unexpected death in epilepsy (SUDEP) risk factors. Expert Rev Neurother. 2018;18(4):265–74.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Neath Port Talbot CLDT, Mental Health & Learning Disability Delivery UnitAbertawe Bro Morgannwg University Health BoardSwanseaUK
  2. 2.Cornwall Partnership NHS Foundation TrustTruroUK
  3. 3.Exeter Medical School, Knowledge SpaRoyal Cornwall HospitalTruroUK

Personalised recommendations